Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens
Open Access
- 1 April 1999
- Vol. 44 (4) , 463-467
- https://doi.org/10.1136/gut.44.4.463
Abstract
BACKGROUND: The increasing use of macrolides especially in the treatment ofHelicobacter pylori infection has led to an increase in resistant strains. The resistance of H pylori to macrolides, especially clarithromycin, is one of the major causes of eradication failure. In H pylori, clarithromycin resistance is due to point mutations localised in domain V of 23S rRNA.AIM: To develop a molecular technique based on amplification of a relevant fragment of the 23S rRNA and colorimetric hybridisation in liquid phase to detect directly in biopsy specimens the type of mutation associated with resistance of H pylori to clarithromycin.METHODS: Gastric biopsy samples from 61 patients were submitted to this test. The results were compared with standard methods (determination of minimal inhibition concentration, polymerase chain reaction/restriction fragment length polymorphism, and/or DNA sequencing) in order to evaluate the test and to define the cut off values, specificity, and sensitivity.RESULTS: The 14 biopsy samples in which H pylori was not detected did not give a positive result in any assay, and the 14 samples harbouring strains susceptible to clarithromycin gave a positive result with the wild type probe as expected. The 33 biopsy specimens containing resistant strains always gave a positive signal with one of the probes detecting resistant organisms, but in eight cases they also reacted with the wild type probe, indicating that a mixture of resistant and susceptible organisms was present.CONCLUSION: The importance of this new assay is that it allows the detection of multiple genotypes corresponding to either heterogeneous genotypes or mixed infections. Moreover, it allows in a single step not only the detection of H pylori but also the determination of its susceptibility to clarithromycin directly in biopsy specimens without the need for culture.Keywords
This publication has 13 references indexed in Scilit:
- Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patientsAntimicrobial Agents and Chemotherapy, 1997
- The complete genome sequence of the gastric pathogen Helicobacter pyloriNature, 1997
- Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.Journal of Antimicrobial Chemotherapy, 1997
- One‐week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistanceAlimentary Pharmacology & Therapeutics, 1997
- Identification of a 23S rRNA Gene Mutation in Clarithromycin‐Resistant Helicobacter pyloriHelicobacter, 1996
- Mechanism of clarithromycin resistance in clinical isolates ofHelicobacter pyloriFEMS Microbiology Letters, 1996
- Rapid diagnosis of Mycobacterium tuberculosis infections by an ELISA-like detection of polymerase chain reaction productsMolecular and Cellular Probes, 1995
- Erythromycin resistance by ribosome modificationAntimicrobial Agents and Chemotherapy, 1995
- Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genesAntimicrobial Agents and Chemotherapy, 1990
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977